PLEKHA1 and head and neck squamous cell carcinoma: PLEKHA1-TACC2 transcripts are present in ESCC (66/404, 16.3%) and head and neck squamous cell carcinoma (58/402, 14.4%) tissues, correlated with poor prognosis of patients.